AXXCESS WEALTH MANAGEMENT, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
AXXCESS WEALTH MANAGEMENT, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$474,237
-23.9%
14,998
-1.9%
0.02%
-64.4%
Q2 2023$623,567
+12.7%
15,291
+3.0%
0.04%
+7.1%
Q1 2023$553,534
+11.9%
14,852
+4.8%
0.04%
+2.4%
Q4 2022$494,531
-51.2%
14,174
-21.7%
0.04%
-57.3%
Q3 2022$1,013,000
+1.5%
18,102
-6.1%
0.10%
+4.3%
Q2 2022$998,000
-29.1%
19,285
-0.4%
0.09%
-16.4%
Q1 2022$1,407,000
-50.6%
19,362
-19.7%
0.11%
-47.1%
Q4 2021$2,850,00024,1010.21%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders